You are here

Article info

Article menu
Download PDFPDF
Hepatology
Original article
Anti-GP2 IgA autoantibodies are associated with poor survival and cholangiocarcinoma in primary sclerosing cholangitis

Authors

  • Sebastian Torben Jendrek Molecular Gastroenterology, Medical Department 1, University of Lübeck, Lübeck, Germany Institute for Anatomy, University of Lübeck, Lübeck, Germany PubMed articlesGoogle scholar articles
  • Daniel Gotthardt Section of Liver Transplantation, Medical Department IV, University Hospital Heidelberg, Heidelberg, Germany PubMed articlesGoogle scholar articles
  • Thomas Nitzsche Institute for Experimental Immunology, Euroimmun Corp., Lübeck, Germany PubMed articlesGoogle scholar articles
  • Laila Widmann Section of Liver Transplantation, Medical Department IV, University Hospital Heidelberg, Heidelberg, Germany PubMed articlesGoogle scholar articles
  • Tobias Korf Molecular Gastroenterology, Medical Department 1, University of Lübeck, Lübeck, Germany PubMed articlesGoogle scholar articles
  • Maike Anna Michaels Molecular Gastroenterology, Medical Department 1, University of Lübeck, Lübeck, Germany PubMed articlesGoogle scholar articles
  • Karl-Heinz Weiss Section of Liver Transplantation, Medical Department IV, University Hospital Heidelberg, Heidelberg, Germany PubMed articlesGoogle scholar articles
  • Evaggelia Liaskou Centre for Liver Research and NIHR Birmingham Liver Biomedical Research Unit, Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK PubMed articlesGoogle scholar articles
  • Mette Vesterhus Department of Transplantation Medicine, Norwegian PSC Research Center, Oslo University Hospital Rikshospitalet, Oslo, Norway National Centre for Ultrasound in Gastroenterology, Haukeland University Hospital, Bergen, Norway PubMed articlesGoogle scholar articles
  • Tom Hemming Karlsen Department of Transplantation Medicine, Norwegian PSC Research Center, Oslo University Hospital Rikshospitalet, Oslo, Norway Division of Cancer Medicine, Surgery and Transplantation, Research Institute of Internal Medicine and Section of Gastroenterology, Oslo University Hospital Rikshospitalet, Oslo, Norway Faculty of Medicine, Institute of Clinical Medicine and K. G. Jebsen Inflammation Research Centre, University of Oslo, Oslo, Norway PubMed articlesGoogle scholar articles
  • Swantje Mindorf Institute for Experimental Immunology, Euroimmun Corp., Lübeck, Germany PubMed articlesGoogle scholar articles
  • Peter Schemmer Department of General, Visceral and Transplant Surgery, University Hospital Heidelberg, Heidelberg, Germany PubMed articlesGoogle scholar articles
  • Florian Bär Molecular Gastroenterology, Medical Department 1, University of Lübeck, Lübeck, Germany PubMed articlesGoogle scholar articles
  • Bianca Teegen Institute for Experimental Immunology, Euroimmun Corp., Lübeck, Germany PubMed articlesGoogle scholar articles
  • Torsten Schröder Molecular Gastroenterology, Medical Department 1, University of Lübeck, Lübeck, Germany Institute for Systemic Inflammation Research, University of Lübeck, Lübeck, Germany PubMed articlesGoogle scholar articles
  • Marc Ehlers Institute for Systemic Inflammation Research, University of Lübeck, Lübeck, Germany PubMed articlesGoogle scholar articles
  • Christoph Matthias Hammers Department of Dermatology, University of Lübeck, Lübeck, Germany PubMed articlesGoogle scholar articles
  • Lars Komorowski Institute for Experimental Immunology, Euroimmun Corp., Lübeck, Germany PubMed articlesGoogle scholar articles
  • Hendrik Lehnert Molecular Gastroenterology, Medical Department 1, University of Lübeck, Lübeck, Germany PubMed articlesGoogle scholar articles
  • Klaus Fellermann Molecular Gastroenterology, Medical Department 1, University of Lübeck, Lübeck, Germany PubMed articlesGoogle scholar articles
  • Stefanie Derer Molecular Gastroenterology, Medical Department 1, University of Lübeck, Lübeck, Germany PubMed articlesGoogle scholar articles
  • Johannes Roksund Hov Department of Transplantation Medicine, Norwegian PSC Research Center, Oslo University Hospital Rikshospitalet, Oslo, Norway Division of Cancer Medicine, Surgery and Transplantation, Research Institute of Internal Medicine and Section of Gastroenterology, Oslo University Hospital Rikshospitalet, Oslo, Norway Faculty of Medicine, Institute of Clinical Medicine and K. G. Jebsen Inflammation Research Centre, University of Oslo, Oslo, Norway PubMed articlesGoogle scholar articles
  • Christian Sina Molecular Gastroenterology, Medical Department 1, University of Lübeck, Lübeck, Germany PubMed articlesGoogle scholar articles
  1. Correspondence to Professor Christian Sina, Medical Department 1, University of Lübeck, Ratzeburger Allee 160, Lübeck 23538, Germany; christian.sina{at}uk-sh.de
View Full Text

Citation

Jendrek ST, Gotthardt D, Nitzsche T, et al
Anti-GP2 IgA autoantibodies are associated with poor survival and cholangiocarcinoma in primary sclerosing cholangitis
Gut 2017;66:137-144.

Publication history

  • Received February 26, 2016
  • Revised June 19, 2016
  • Accepted June 20, 2016
  • First published July 12, 2016.
Online issue publication 
December 07, 2016

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/